Meeting
2024 ASCO Genitourinary Cancers Symposium
Cardiovascular medications and overall survival in metastatic hormone-sensitive prostate cancer.
Authors
Kara Ingram
Saint Louis University School of Medicine, St. Louis, MO
Kara Ingram , Carley Pickett , Daniel B. Eaton Jr., Steven Tohmasi , Krishny Karunanandaa , Deepika Gopukumar , Varun Puri , Martin W. Schoen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 75)
DOI
10.1200/JCO.2024.42.4_suppl.75
Abstract #
75
Poster Bd #
C10
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Number of prescription medications and overall survival in veterans with metastatic hormone-sensitive prostate cancer.
First Author: Krishny Karunanandaa
Poster
2018 Genitourinary Cancers Symposium
Epidemiology and survival disparities of prostate cancer in Appalachian Kentucky.
First Author: Zin Myint
Poster
2014 ASCO Annual Meeting
Metformin (M), diabetes (DM), and colorectal cancer (CRC) survival among U.S. veterans.
First Author: Jessica K Paulus
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of body-mass index (BMI) with age, PSA, and survival in metastatic prostate cancer.
First Author: Martin W. Schoen